Liver apoptosis

Journal of Hepatology, Supplement

Volumn 26, Issue 2, 1997, Pages 1-11

  Feldmann, Gérard ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSERM   (France)

Author keywords

Apoptosis; Liver cells

Indexed keywords

ANIMAL TISSUE; APOPTOSIS; CONFERENCE PAPER; ELECTRON MICROSCOPY; ETIOLOGY; HUMAN; HUMAN TISSUE; LIVER CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SWINE;

EID: 0030982279     PISSN: 01695185     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0168-8278(97)80491-6     Document Type: Conference Paper

References (117)

1. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239-57.
2. Biava C, Mukhlova-Montiel M. Electron microscopic observations on Councilman-like acidophilic bodies and other forms of acidophilic changes in human liver cells. Am J Pathol 1965; 46: 775-802.
3. Klion FM, Schaffner F. The ultrastucture of acidophilic "Councilman-like" bodies in the liver. Am J Pathol 1966; 48: 755-67.
4. Kerr JFR. An electron microscopy study of liver cell necrosis due to albitocin. Pathology 1970; 2: 251-9.
5. Ellis HM, Horvitz HR. Genetic control of programmed cell death in the nematode C. elcgans. Cell 1-986; 44: 817-29.
6. Williams GT, Smith CA, McCarthy NJ, Grimes EA. Apoptosis: final control point in cell biology. Trends Cell Biol 1992; 2: 263-7.
7. Williams GT, Smith CA. Molecular regulation of apoptosis: genetic controls on cell death. Cell 1993; 74: 777-9.
8. Bursch W, Paffe S, Putz B, Barthel G, Schulte-Hermann R. Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats. Carcinogenesis 1990; 11: 847-53.
9. Popper H. Hepatocellular degeneration and death. In: Arias IM, Jakoby WB, Popper H, Schachter D, Shafritz DA, eds. The Liver. Biology and Pathobiology. 2nd edn. New York: Raven Press, 1988; 1087-103.
10. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992, 119: 493-501.
11. Wijsman JH, Jonker RR, Keijzer R, Van De Velde CJH, Cornelisse CJH, Van Dierendonck JHV. A new method to detect apoptosis in paraffin section: in silti end-labeling of fragmented DNA. J Histochem Cytochem 1993; 41: 7-12.
12. Hully JR, Chang L, Schwall RH, Widmer HR, Terrell TG, Gillett NA. Induction of apoptosis in the murine liver with recombinant human activin A. Hepatology 1994; 20: 85461.
13. Grasl-Kraupp B, Ruttkay-Nedecky B, Koudelka H, Bukowska K, Bursch W, Schulte-Hermann R. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. Hepatology 1995; 21: 1465-8.
14. Benedetti A, Jézéquel AM, Orlandi F. Preferential distribution of apoptotic bodies in acinar zone 3 of normal human and rat liver. J Hepatol 1988; 7: 319-24.
15. Goldin RD, Hunt NC, Clark J, Wickramasinghe SN. Apoptotic bodies in a murine model of alcoholic liver disease: reversibility of ethanol-induced changes. J Pathol 1993; 171: 73-6.
16. Arber N, Zajicek G, Ariel I. The streaming liver. II. Hepatocyte life history. Liver 1988; 8: 80-7.
17. Barrett JC, Preston G. Apoptosis and cellular senescence : forms of irreversible growth arrest. In: Tomei LD, Cope FO, eds. Apoptosis II: The Molecular Basis of Apoptosis in Disease. New York: Cold Spring Harbor Laboratory Press, 1994; 253-81.
18. Scothorne RJ, MacSween RNM. The streaming liver: a slow, divided flow. Hepatology 1986; 6: 1050-2.
19. Searle J, Harmon BV, Bishop CJ, Kerr JFR. The significance of cell death by apoptosis in hepatobiliary disease. J Gastroenterol Hepatol 1987; 2: 77-96.
20. Columbano A, Ledda-Columbano GM, Coni PP, Faa G, Liguori C, Santa Cruz G, Pani P. Occurrence of cell death (apoptosis) during the involution of liver hyperplasia. Lab Invest 1985; 52: 670-5.
21. Terada T, Nakanuma Y. Detection of apoptosis and expression of apoptosis-related proteins during human intrahepatic bile duct development. Am J Pathol 1995; 146: 67-74.
22. Arends MJ, Wyllie AH. Apoptosis: mechanisms and roles in pathology. Int Rev Exp Pathol 1991; 32: 223-54.
23. Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980; 284: 555-6.
24. Wyllie AH, Morris RG, Smith AL, Dunlop D. Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol 1984; 142: 67-77.
25. Martin SJ. Apoptosis: suicide, execution or murder? Trends Cell Biol 1993; 3: 141-4.
26. Peitsch MC, Mannherz HG, Tschopp J. The apoptosis endonucleases: cleaning up after cell death? Trends Cell Biol 1994; 4: 37-41.
27. Patel T, Gores GJ. Apoptosis and hepatobiliary disease. Hepatology 1995; 21: 1725-41.
28. Fesus L, Thomazy V, Falus A. Induction and activation of tissue transglutaminase during programmed cell death. Febs Lett 1987; 224: 104-8.
29. McCabe MJ, Nicotera P, Orrenius S. Calcium-dependent cell death. Role of the endonuclease, protein kinase C, and chromatin conformation. An NY Acad Sci 1992; 663: 26978.
30. 2+ antagonists inhibit DNA fragmentation and toxic cell death induced by acetaminophen. FASEB J 1993; 7: 453-63.
31. Martin SJ, Green DR. Protease activation during apoptosis: death by a thousand cuts? Cell 1995; 82: 349-52.
32. Oberhammer F, Wilson JW, Dive C, Morris ID, Hickman JA, Wakeling AE, Walker PR, Sikorska M. Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J 1993; 12: 3679-84.
33. Compton MM. A biochemical hallmark of apoptosis: internucleosomal degradation of the genome. Cancer Metast Rev 1992; 11: 105-19.
34. Cohen GM, Sun XM, Snowden RT, Dinsdale D, Skilleter DN. Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. BiochemJ 1992; 286: 331-4.
35. Piacentini M, Davies PJA, Fesus L. Tissue transglutaminase in cells undergoing apoptosis. In: Tomei LD, Cope FO, eds. Apoptosis II: The Molecular Basis of Apoptosis in Disease. New York: Cold Spring Harbor Laboratory Press, 1994; 143-64.
36. Piacentini M, Ceru MP, Dini L, Di Rao M, Piredda L, Thomazy V, Davies PJA, Fesus L. In vivo and in vitro induction of "tissue" transglutaminase in rat hepatocytes by retinoic acid. Biochim Biophys Acta 1992; 1135: 171-9.
37. McConkey DJ, Orrenius S. Signal transduction pathways to apoptosis. Trends Cell Biol 1994; 4: 370-5.
38. Sanchez V, Lucas M, Sanz A, Goberna R. Decreased protein kinase C activity is associated with programmed cell death (apoptosis) in freshly isolated rat hepatocytes. Biosci Rep 1992; 12: 199-205.
39. Tsukidate K, Yamamoto K, Snyder JW, Farber JL. Microtubule antagonists activate programmed cell death (apoptosis) in cultured rat hepatocytes. Am J Pathol 1993; 143: 918-25.
40. Ni R, Tomita Y, Matsuda K, Ichihara A, Ishimura K, Ogasawara J, Nagata S. Fas-mediated apoptosis in primary cultured mouse hepatocytes. Exp Cell Res 1994; 215: 332-7.
41. Fesus L, Thomazy V, Autuori F, Ceru MP, Tarcsa E, Piacentini M. Apoptotic hepatocytes become insoluble in deter-gents and chaotropic agents as a result of transglutaminase action. Febs Lett 1989; 245: 150-4.
42. Savill J, Fadok V, Henson P, Haslett C. Phagocyte recognition of cells undergoing apoptosis. Immunol Today 1993; 14: 131-6.
43. Dini L, Autuori F, Lentini A, Oliverio S, Piacentini M. The clearance of apoptotic cells in the liver is mediated by the asialoglycoprotein receptor. Febs Lett 1992; 296: 174-8.
44. Dini L, Falasca L, Lentini A, Mattioli P, Piacentini M, Piredda L, Autuori F. Galactose-specific receptor modulation related to the onset of apoptosis in rat liver. Eur J Cell Biol 1993; 61: 329-37.
45. Martin SJ, Green DR, Cotter TG. Dicing with death: dissecting the components of the apoptosis machinery. TIBS 1994; 19: 26-30.
46. Kerr JFR, Winterford CM, Harmon BV. Apoptosis. Its significance in cancer and cancer therapy. Cancer 1994; 73: 2013-26.
47. Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994; 124: 1-6.
48. Lithgow T, Van Driel R, Bertram JF, Strasser A. The protein product of the oncogene bcl-2 is a component of the nuclear envelope, the endoplasmic reticulum, and the outer mitochondrial membrane. Cell Growth Diff 1994; 5: 411-7.
49. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993; 75: 241-51.
50. Kane DJ, Sarafian TA, Anton R, Hahn H, Gralla EB, Valentine SJ, Ord T, Breseden DE. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 1993; 262: 1274-7.
51. Charlotte F, L'Hermine A, Martin N, Geleyn Y, Nollet M, Gaulard P, Zafrani ES. Immunohistochemical detection of bcl-2 protein in normal and pathological human liver. Am J Pathol 1994; 144: 460-5.
52. Zhao M, Zhang NX, Economou M, Blaha I, Laissue JA, Zimmermann A. Immunohistochemical detection of bcl-2 protein in liver lesions: bcl-2 protein is expressed in hepatocellular carcinomas but not in liver cell dysplasia. Histopathology 1994; 25: 237-45.
53. Krajewski S, Krajewska M, Shabaik A, Miyashita T, Wang GH, Reed JC. Immunohistochemical determination of in vivo distribution of bax, a dominant inhibitor of bcl-2. Am J Pathol 1994; 145: 1323-36.
54. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell 1993; 74: 609-19.
55. Nagata S, Golstein P. The fas death factor. Science 1995; 267:1449-55.
56. Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y, Itoh N, Suda T, Nagata S. Lethal effect of the anti-fas antibody in mice. Nature 1993; 364: 806-9.
57. Rouquet N, Allemand I, Molina T, Bennoun M, Briand P, Joulin V. Fas-dependent apoptosis is impaired by SV40 Tantigen in transgenic liver. Oncogene 1995; 11: 1061-7.
58. Hiramatsu N, Hayashi N, Katayama K, Mochizuki K, Kawanishi Y, Kasahara A, Fusamoto H, Kamada T. Immunohistochemical detection of fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology 1994; 19: 1354-9.
59. Mita E, Hayashi N, lio S, Takehara T, Hijioka T, Kasahara A, Fusamoto H, Kamada T. Role of fas ligand in apoptosis induced by hepatitis C virus infection. Biochem Biophys Res Commun 1994; 204: 468-74.
60. Kerr JFR, Searle J, Halliday WJ, Roberts I, Cooksley WGE, Halliday JW, Holder L, Burnett W, Powell LW The nature of piecemeal necrosis in chronic active hepatitis. Lancet 1979; ii: 827-8.
61. Lacronique V, Mignon A, Fabre M, Viollet B, Rouquet N, Molina T, Portkeu A, Henrion A, Bouscary D, Varlet P, Joulin V, Kahn A. Bcl-2 protects from lethal hepatic apoptosis induced by the anti-fas antibody in mice. Nature Med 1996; 2: 80-6.
62. Askew DS, Ashmun RA, Simmons BC, Cleveland JL. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 1991; 6: 1915-22.
63. Schulte-Hermann R, Bursch W, Grasl-Kraupp B. Active cell death (apoptosis) in liver biology and disease. In: Boyer JL, Ockner RK, eds. Progress in Liver Diseases. Philadelphia: Saunders, 1995, Vol 13: 1-35.
64. Bressac B, Galvin KM, Liany TJ, Isselbacher KJ, Wands JR, Ortuk M. Abnormal structure and expression of p53 gene in human hepatocellular carcinoma. Proc Natl Acad Sci USA 1990; 87: 1973-7.
65. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A. Oren M. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 1991; 352: 345-7.
66. Helvering LM, Richardson KK, Horn DM, Wightman KA, Hall RL, Smith WC, Engelhardt JA, Richardson FC. Expression of TRPM-2 during involution and regeneration of the rat liver. Cancer Lett 1993; 71: 133-42.
67. Ledda-Columbano GM, Coni P, Faa G, Manenti G, Columbano A. Rapid induction of apoptosis in rat liver by cycloheximide. Am J Pathol 1992; 140: 545-9.
68. Hockenbery D. Defining apoptosis. Am J Pathol 1995; 146: 16-9.
69. Ishak KG, Walker DH, Coetzer JAW, Gardner JJ, Gorelkin L. Viral hemorrhagic fevers with hepatic involvement: pathologic aspects with clinical correlations. In: Popper H, Schaffner F, eds. Progress in Liver Diseases, Vol 7. New York: Grune & Stratton, 1982; 495-515.
70. Dienes HP, Popper H, Arnold W, Lobeck H. Histologie observations in human hepatitis non-A, non-B. Hepatology 1982; 2: 562-71.
71. Smets LA. Programmed cell death (apoptosis) and response to anti-cancer drugs. Anti-Cancer Drugs 1994; 5: 3-9.
72. Snover DC, Sibley RK, Freese DK, Sharp HL, Bloomer JR, Najarian JS, Ascher NL. Orthotopic liver transplantation: a pathological study of 63 serial liver biopsies from 17 patients with special reference to the diagnostic features and natural history of rejection. Hepatology 1984; 4: 1212-22.
73. Nawaz S, Fennell RH. Apoptosis of bile duct epithelial cells in hepatic allograft rejection. Histopathology 1994; 25: 137-42.
74. Afford SC, Hubscher S, Strain AJ, Adams DH, Neuberger JM. Apoptosis in the human liver during allograft rejection and end-stage liver disease. J Pathol 1995; 176: 373-80.
75. Bernuau D, Feldmann G, Degott C, Gisselbrecht C. Ultrastructural lesions of bile ducts in primary biliary cirrhosis. A comparison with the lesions observed in graft versus host disease. Hum Pathol 1981; 12: 782-93.
76. Phillips MJ, Poucell S, Patterson J, Valencia P. The Liver. An Atlas and Text of Ultrastructural Pathology. New York: Raven Press, 1987.
77. Ikeda K, Kinoshita H, Hirohashi K, Kubo S, Kaneda K. The ultrastructure, kinetics and intralobular distribution of apoptotic hepatocytes after portal branch ligation with special reference to their relationship to necrotic hepatocytes. Arch Histol Cytol 1995; 58: 171-84.
78. Bursch W, Taper HS, Lauer B, Schulte-Hermann RS. Quantitative histological and histochemical studies on the occurrence and stages of controlled cell death (apoptosis) during regression of rat liver hyperplasia. Virchows Arch 1985; 50: 153-66.
79. Tessitore L, Valente G, Bonelli G, Costelli P, Baccino FM. Regulation of cell turnover in the livers of tumour-bearing rats: occurrence of apoptosis. Int J Cancer 1989; 44: 697-700.
80. Bhathal PS, Gall JAM. Deletion of hyperplastic biliary epithelial cells by apoptosis following removal of the proliferative stimulus. Liver 1985; 5: 311-25.
81. Searle J, Kerr JFR, Battersby C, Egerton WS, Balderson G, Burnett W. An electron microscopic study of the mode of donor cell death in unmodified rejection of pig liver allografts. Aust J Exp Biol Med Sci 1977; 55: 401-6.
82. Astarcioglu I, Delautier D, Adam R, Gigou M, Bismuth H, Feldmann G. The influence of the temperature of storage on survival and ultrastructure of transplanted UW-preserved rat liver grafts. Transplantation 1993; 55: 230-4.
83. Krams SM, Egawa H, Quinn MB, Villanueva JC, GarciaKennedy R, Martinez OM. Apoptosis as a mechanism of cell death in liver allograft rejection. Transplantation 1995; 59: 621-5.
84. Columbano A, Ledda-Columbano GM, Rao PM, Rajalakshmi S, Sarma DSR. Occurrence of cell- death (apoptosis) in preneoplastic and neoplastic liver cells. A sequential study. Am J Pathol 1984; 116: 441-6.
85. Zerban H, Radig S, Kopp-Schneider A, Bannasch P. Cell proliferation and cell death (apoptosis) in hepatic preneoplasia and neoplasia are closely related to phenotypic cellular diversity and instability. Carcinogenesis 1994; 15: 2467-73.
86. Grasl-Kraupp B, Bursch W, Ruttkay-Nedecky B, Wagner A, Lauer B, Schulte-Hermann R. Food restriction eliminated preneoplastic cells through apoptosis and antagonizes carcinogenesis in rat liver. Proc Natl Acad Sci USA 1994; 91: 9995-9.
87. James SJ, Muskhelishvili L. Rates of apoptosis and proliferation vary with caloric intake and may influence incidence of spontaneous hepatoma in C57BL/6XC3H FI mice. Cancer Res 1994; 54: 5508-10.
88. Benedetti A, Jézéquel AM, Orlandi F. A quantitative evaluation of apoptotic bodies in rat liver. Liver 1988; 8: 172-7.
89. Baroni GS, Marucci L, Benedetti A, Mancini R, Jezequel AM, Orlandi F. Chronic ethanol feeding increases apoptosis and cell proliferation in rat liver. J Hepatol 1994; 20: SOS13.
90. Yacoub LK, Fogt F, Griniuviene B, Nanji AA. Apoptosis and bcl-2 protein expression in experimental alcoholic liver disease in the rat. Alcohol Clin Exp Res 1995; 19: 854-9.
91. Pritchard DJ, Butler WH. Apoptosis - The mechanism of cell death in dimethylnitrosamine-induced hepatotoxicity. J Pathol 1989; 158: 253-60.
92. ++-endonuclease and poly (ADP-ribose) polymerase inhibitors in mice. J Pharmacol Exp Ther 1992; 263: 347-52.
93. Ledda-Columbano GM, Coni P, Curto M, Giacomini L, Faa G, Oliverio S, Piacentini M, Columbano A. Induction of two different modes of cell death, apoptosis and necrosis, in rat liver after a single dose of thioacetamide. Am J Pathol 1991; 139: 1099-109.
94. Cascales M, Alvarez A, Gasco P, Fernandez-Simon L, Sanz N, Bosca L. Cocaine-induced liver injury in mice elicits specific changes in DNA ploidy and induces programmed death of hepatocytes. Hepatology 1994; 20: 992-1001.
95. Faa G, Ledda-Columbano GM, Ambu R, Congiu T, Coni P, Riva A, Columbano A. An electron microscopic study of apoptosis induced by cycloheximide in rat liver. Liver 1994; 14: 270-8.
96. Bursch W, Oberhammer F, Schulte-Hermann R. Cell death by apoptosis and its protective role against disease. Trends Pharmacol Sci 1992; 13: 245-51.
97. Medline A, Schaffner F, Popper H. Ultrastructural features in galactosamine-induced hepatitis. Exp Mol Pathol 1970; 12:201-11.
98. Bose S, Mathur M, Nayak NC. A light and electron microscopic study on apoptotic bodies in acute aflatoxin B| induced injury in the rat liver. Indian J Med Res 1991; 94: 134-8.
99. King TP, Bremmer I. Autophagy and apoptosis in liver during the prehaemolytic phase of chronic copper poisoning in sheep. J Comp Pathol 1979; 89: 515-30.
100. Kaneko Y, Tsukamoto A. Apoptosis and p53 protein expression in human hepatoma cells induced by etoposide, mitomycin C and thapsigargin. Intern Hepatol Commun 1994; 2: 305-9.
101. Bayly AC, Roberts RA, Dive C. Suppression of liver cell apoptosis in vitro by the non-genotoxic hepatocarcinogen and peroxisome proliferator nafenopin. J Cell Biol 1994; 125: 197-203.
102. Roberts R A, Soames AR, Gill JH, James NH, Wheeldon EB. Non-genotoxic hepatocarcinogens stimulate DNA synthesis and their withdrawal induces apoptosis, but in different hepatocyte populations. Carcinogenesis 1995; 16: 1693-8.
103. Fukuda K, Kojiro M, Chiu JF. Demonstration of extensive chromatin cleavage in transplanted Morris hepatoma 7777 tissue: apoptosis or necrosis? Am J Pathol 1993; 142: 935-46.
104. Laukka MA, Wang KK, Bonner JA. Apoptosis occurs in lymphoma cells but not in hepatoma cells following ionizing radiation and photodynamic therapy. Dig Dis Sci 1994; 39: 2467-75.
105. Maeda S, Kimura H, Koga N, Lin KH, Saito T. Cell den-sity-dependent DNA fragmentation and its suppression by heparin in primary culture of adult rat hepatocytes. Biochem Biophys Res Commun 1993; 195: 270-5.
106. Patel T, Bronk SF, Gores GJ. Increases of intracellular magnesium promote glycodeoxycholate-induced apoptosis in rat hepatocytes. J Clin Invest 1994; 94: 2183-92.
107. 2+-endonuclease, DNA repair, and glutathione depletion inhibitors on DNA fragmentation and cell death. Toxicol Appl Pharmacol 1992; 112: 32-40.
108. Natoli G, lanni A, Costanzo A, De Petrillo G, Ilari I, Chirillo P, Balsano C, Levrero M. Resistance to fas-mediated apoptosis in human hepatoma cells. Oncogene 1995; 11: 1157-64.
109. Oberhammer FA, Pavelka M, Sharma S, Tiefenbacher R, Purchio AF, Bursch W, Schuhe-Hermann R. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor β1. Proc Natl Acad Sci USA 1992; 89: 5408-12.
110. Oberhammer F, Bursch W, Parzefall W, Breit P, Erber E, Stadier M, Schulte-Hermann R. Effect of transforming growth factor β on cell death of cultured rat hepatocytes. Cancer Res 1991; 51: 2478-85.
111. Lin JK, Chou CK. In vitro apoptosis in the human hepatoma cell line induced by transforming growth factor β1. Cancer Res 1992; 52: 385-8.
112. Ohno K, Ammann P, Fasciati R, Maier P. Transforming growth factor β1 preferentially induces apoptotic cell death in rat hepatocytes cultured under pericentral-equivalent conditions. Toxicol Appl Pharmacol 1995; 132: 227-36.
113. Benedetti A, Di Sario A, Baroni GS, Jezequel AM. T. Transforming growth factor β1 increases the number of apoptotic bodies and decreases intracellular pH in isolated periportal and perivenular rat hepatocytes. Hepatology 1995; 22: 1488-98.
114. Schwall RH, Robbins K, Jardieu P, Chang L, Lai C, Terrell TG. Activin induces cell death in hepatocytes in vivo and in vitro. Hepatology 1993; 18: 347-56.
115. Leist M, Gantner F, Bohlinger I, Germann PG, Tiegs G, Wendel A. Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-α requires transcriptional arrest. J Immunol 1994; 153: 1778-88.
116. Leist M, Gantner F, Bohlinger I, Tiegs G, Germann PG, Wendel A. Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am J Pathol 1995; 146: 1220-34.
117. Shinagawa T, Yoshioka K, Kakumu S, Wakita T, Ishikawa T, Itoh Y, Takayanagi M. Apoptosis in cultured rat hepatocytes: the effects of tumour necrosis factor or and interferon J. J Pathol 1991; 165: 247-53.